NLRP3 overexpression exacerbated synovium tissue degeneration in juvenile collagen-induced arthritis

Fater A Khadour1,2,3, Younes A Khadour2,4, Tao Xu5

  • 1Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095#, Jie-Fang Avenue, Qiaokou District, Wuhan, 430030, Hubei, China.

Scientific Reports
|February 27, 2025
PubMed

Insights

Nod-like receptor 3 (NLRP3) drives synovial inflammation in juvenile idiopathic arthritis (JIA). Inhibiting NLRP3 reduces inflammation and offers a potential therapeutic target for JIA management.

Area of Science:

  • Immunology
  • Rheumatology
  • Cell Biology

Background:

  • Juvenile idiopathic arthritis (JIA) is a leading cause of childhood disability, characterized by chronic synovial inflammation.
  • The Nod-like receptor 3 (NLRP3) inflammasome is implicated in autoimmune diseases, but its role in JIA pathogenesis is not fully understood.

Purpose of the Study:

  • To elucidate the specific mechanism of NLRP3 in regulating synovial inflammation within the context of juvenile collagen-induced arthritis (CIA).
  • To investigate the NLRP3-NF-κB signaling axis and its impact on JIA progression.

Main Methods:

  • Established a juvenile CIA rat model using Sprague-Dawley rats (2-3 weeks old).
  • Utilized adeno-associated virus vectors for NLRP3 knockdown or overexpression in the knee joints of CIA rats.
  • Analyzed NLRP3 expression, NF-κB pathway activation, autophagy, and pyroptosis in synovial tissues.

Main Results:

  • NLRP3 expression was significantly increased in the synovial tissue of juvenile CIA rats.
  • Knockdown of NLRP3 inhibited inflammation and alleviated synovial inflammation.
  • NLRP3 activation upregulated the NF-κB signaling pathway, impaired autophagy, and promoted pyroptosis in the synovium.

Conclusions:

  • NLRP3 plays a critical role in promoting synovial inflammation in juvenile CIA.
  • Targeting the NLRP3 inflammasome presents a potential therapeutic strategy for managing JIA.